EuroQoL in assessment of the effect of pulmonary rehabilitation COPD patients.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

EuroQoL in assessment of the effect of pulmonary rehabilitation COPD patients. / Ringbaek, Thomas; Brøndum, Eva; Martinez, Gerd; Lange, Peter.

I: Respiratory Medicine, Bind 102, Nr. 11, 2008, s. 1563-67.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Ringbaek, T, Brøndum, E, Martinez, G & Lange, P 2008, 'EuroQoL in assessment of the effect of pulmonary rehabilitation COPD patients.', Respiratory Medicine, bind 102, nr. 11, s. 1563-67. https://doi.org/10.1016/j.rmed.2008.06.016

APA

Ringbaek, T., Brøndum, E., Martinez, G., & Lange, P. (2008). EuroQoL in assessment of the effect of pulmonary rehabilitation COPD patients. Respiratory Medicine, 102(11), 1563-67. https://doi.org/10.1016/j.rmed.2008.06.016

Vancouver

Ringbaek T, Brøndum E, Martinez G, Lange P. EuroQoL in assessment of the effect of pulmonary rehabilitation COPD patients. Respiratory Medicine. 2008;102(11):1563-67. https://doi.org/10.1016/j.rmed.2008.06.016

Author

Ringbaek, Thomas ; Brøndum, Eva ; Martinez, Gerd ; Lange, Peter. / EuroQoL in assessment of the effect of pulmonary rehabilitation COPD patients. I: Respiratory Medicine. 2008 ; Bind 102, Nr. 11. s. 1563-67.

Bibtex

@article{c25685fb348540ca81a0484f6889bc13,
title = "EuroQoL in assessment of the effect of pulmonary rehabilitation COPD patients.",
abstract = "BACKGROUND: The effect of pulmonary rehabilitation on EuroQol in COPD patients has not been investigated previously. METHODS/MATERIALS: Two hundred and twenty nine consecutive COPD patients who had completed a 7-week pulmonary rehabilitation programme were assessed with EuroQol five-dimension questionnaire (EQ-5D), endurance shuttle walk test (ESWT), and the St George's Respiratory Questionnaire (SGRQ) before and after the programme, and at the 3-month follow-up visit. RESULTS: Two hundred and two (88.4%) patients had FEV(1)<50% predicted and all but four (1.7%) had dyspnoea score at least 3 on MRC scale. At completion of the programme, statistical significant improvements were seen for ESWT 157.3s; p<0.001, EQ-5D utility score -0.019; p=0.03, EQ-5D VAS -2.1; p=0.056, SGRQ total score -2.8units; p<0.001. The effects of rehabilitation on ESWT and SGRQ were maintained at 3-month follow-up (158.9s and -2.9units), while the effect on EQ-5 utility decreased (0.013; p=0.18). At baseline, there was a maximum score ({"}ceiling effect{"}) for EQ-5D utility and EQ VAS in 29 (12.7%) and five (2.2%) of the patients, respectively. After rehabilitation these number increased to 41 (17.9%) and seven (3.1%). CONCLUSIONS: In COPD patients receiving rehabilitation, responsiveness of EQ-5D utility was poor. One explanation might be a {"}ceiling effect{"} of this instrument.",
author = "Thomas Ringbaek and Eva Br{\o}ndum and Gerd Martinez and Peter Lange",
year = "2008",
doi = "http://dx.doi.org/10.1016/j.rmed.2008.06.016",
language = "English",
volume = "102",
pages = "1563--67",
journal = "Respiratory Medicine",
issn = "0954-6111",
publisher = "Elsevier",
number = "11",

}

RIS

TY - JOUR

T1 - EuroQoL in assessment of the effect of pulmonary rehabilitation COPD patients.

AU - Ringbaek, Thomas

AU - Brøndum, Eva

AU - Martinez, Gerd

AU - Lange, Peter

PY - 2008

Y1 - 2008

N2 - BACKGROUND: The effect of pulmonary rehabilitation on EuroQol in COPD patients has not been investigated previously. METHODS/MATERIALS: Two hundred and twenty nine consecutive COPD patients who had completed a 7-week pulmonary rehabilitation programme were assessed with EuroQol five-dimension questionnaire (EQ-5D), endurance shuttle walk test (ESWT), and the St George's Respiratory Questionnaire (SGRQ) before and after the programme, and at the 3-month follow-up visit. RESULTS: Two hundred and two (88.4%) patients had FEV(1)<50% predicted and all but four (1.7%) had dyspnoea score at least 3 on MRC scale. At completion of the programme, statistical significant improvements were seen for ESWT 157.3s; p<0.001, EQ-5D utility score -0.019; p=0.03, EQ-5D VAS -2.1; p=0.056, SGRQ total score -2.8units; p<0.001. The effects of rehabilitation on ESWT and SGRQ were maintained at 3-month follow-up (158.9s and -2.9units), while the effect on EQ-5 utility decreased (0.013; p=0.18). At baseline, there was a maximum score ("ceiling effect") for EQ-5D utility and EQ VAS in 29 (12.7%) and five (2.2%) of the patients, respectively. After rehabilitation these number increased to 41 (17.9%) and seven (3.1%). CONCLUSIONS: In COPD patients receiving rehabilitation, responsiveness of EQ-5D utility was poor. One explanation might be a "ceiling effect" of this instrument.

AB - BACKGROUND: The effect of pulmonary rehabilitation on EuroQol in COPD patients has not been investigated previously. METHODS/MATERIALS: Two hundred and twenty nine consecutive COPD patients who had completed a 7-week pulmonary rehabilitation programme were assessed with EuroQol five-dimension questionnaire (EQ-5D), endurance shuttle walk test (ESWT), and the St George's Respiratory Questionnaire (SGRQ) before and after the programme, and at the 3-month follow-up visit. RESULTS: Two hundred and two (88.4%) patients had FEV(1)<50% predicted and all but four (1.7%) had dyspnoea score at least 3 on MRC scale. At completion of the programme, statistical significant improvements were seen for ESWT 157.3s; p<0.001, EQ-5D utility score -0.019; p=0.03, EQ-5D VAS -2.1; p=0.056, SGRQ total score -2.8units; p<0.001. The effects of rehabilitation on ESWT and SGRQ were maintained at 3-month follow-up (158.9s and -2.9units), while the effect on EQ-5 utility decreased (0.013; p=0.18). At baseline, there was a maximum score ("ceiling effect") for EQ-5D utility and EQ VAS in 29 (12.7%) and five (2.2%) of the patients, respectively. After rehabilitation these number increased to 41 (17.9%) and seven (3.1%). CONCLUSIONS: In COPD patients receiving rehabilitation, responsiveness of EQ-5D utility was poor. One explanation might be a "ceiling effect" of this instrument.

U2 - http://dx.doi.org/10.1016/j.rmed.2008.06.016

DO - http://dx.doi.org/10.1016/j.rmed.2008.06.016

M3 - Journal article

VL - 102

SP - 1563

EP - 1567

JO - Respiratory Medicine

JF - Respiratory Medicine

SN - 0954-6111

IS - 11

ER -

ID: 34121447